Cargando…

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions

Small cell lung cancer (SCLC) is a recalcitrant malignancy with elusive mechanism of pathogenesis and dismal prognosis. Over the past decades, platinum-based chemotherapy has been the backbone treatment for SCLC. However, subsequent chemoresistance after initial effectiveness urges researchers to ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chenyue, Zhang, Chenxing, Wang, Kai, Wang, Haiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349514/ https://www.ncbi.nlm.nih.gov/pubmed/37452395 http://dx.doi.org/10.1186/s12967-023-04338-6

Ejemplares similares

Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples
por: Li, Jia, et al.
Publicado: (2020)

TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti‐CTLA4 treatment
por: Li, Huahua, et al.
Publicado: (2020)

Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma
por: Li, Jia, et al.
Publicado: (2020)

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
por: Zhang, Chenxing, et al.
Publicado: (2020)

Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
por: Zhang, Chenyue, et al.
Publicado: (2021)

Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types
por: Zhang, Chenyue, et al.
Publicado: (2020)

A 5-Gene Signature Is Closely Related to Tumor Immune Microenvironment and Predicts the Prognosis of Patients with Non-Small Cell Lung Cancer
por: Li, Jia, et al.
Publicado: (2020)

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma
por: Li, Jia, et al.
Publicado: (2021)

Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer
por: Shang, Xiaoling, et al.
Publicado: (2023)

Loss of heterozygosity related to TMB and TNB may predict PFS for patients with SCLC received the first line setting
por: Zhang, Chenyue, et al.
Publicado: (2021)

Genetic alternations and immune characteristics in patients with small cell lung cancer
por: Zhang, Chenyue, et al.
Publicado: (2021)

Future Time Perspective and the Achievement of Optimal Best: Reflections, Conceptualizations, and Future Directions for Development
por: Phan, Huy P., et al.
Publicado: (2020)

Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions
por: Lu, Liang, et al.
Publicado: (2022)

Immunomodulatory role of metalloproteases in cancers: Current progress and future trends
por: Wang, Qi, et al.
Publicado: (2022)

Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies
por: Matte, Allan
Publicado: (2022)

Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
por: Abdeldaim, Dalia T., et al.
Publicado: (2023)

Recent progress and future directions of the research on nanoplastic-induced neurotoxicity
por: Han, Seung-Woo, et al.
Publicado: (2023)

Cloud-Native Workload Orchestration at the Edge: A Deployment Review and Future Directions
por: Vaño, Rafael, et al.
Publicado: (2023)

Intratumor heterogeneity is associated with less CD8(+) T cell infiltration and worse survival in patients with small cell lung cancer
por: Zhang, Chenyue, et al.
Publicado: (2022)

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies
por: Wang, Haiyong, et al.
Publicado: (2022)

Application of double-negative T cells in haematological malignancies: recent progress and future directions
por: Chen, Xingchi, et al.
Publicado: (2022)

Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
por: Zhang, Chenyue, et al.
Publicado: (2019)

The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
por: Chi, Huiying, et al.
Publicado: (2017)

Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects
por: Xiao, Zhangang, et al.
Publicado: (2018)

Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III
por: Wang, Haiyong, et al.
Publicado: (2017)

Advanced Hydrogels for Cartilage Tissue Engineering: Recent Progress and Future Directions
por: Hafezi, Mahshid, et al.
Publicado: (2021)

Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
por: Wang, Haiyong, et al.
Publicado: (2018)

Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma
por: Kou, Peisi, et al.
Publicado: (2019)

Epigenetic Reprogramming During Somatic Cell Nuclear Transfer: Recent Progress and Future Directions
por: Wang, Xiangyu, et al.
Publicado: (2020)

Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration
por: Wei, Hongpu, et al.
Publicado: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
por: Zhang, Li, et al.
Publicado: (2020)

The GMA Journal for Medical Education – Recent Achievements and Future Goals
por: Fabry, Götz, et al.
Publicado: (2012)

Unlocking secrets of microbial ecotoxicology: recent achievements and future challenges
por: Hellal, Jennifer, et al.
Publicado: (2023)

Progressive multiple sclerosis: latest therapeutic developments and future directions
por: Faissner, Simon, et al.
Publicado: (2019)

CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2020)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

A Potential New Therapeutic Direction for Fibrosis in the Injured Heart Orchestrated by Cardiac MSCs
por: Cieslik, Katarzyna A.
Publicado: (2022)

Therapeutic peptides: current applications and future directions
por: Wang, Lei, et al.
Publicado: (2022)

Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
por: Sun, Ming-Chen, et al.
Publicado: (2020)

Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions
por: Bond, David A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7fveuuicbeht4t6em2a6hba65d